Non-invasive spinal manipulation for cerebral palsy

SpineX, a California-based medical technology company, has developed the Spinal Cord Innovation in Pediatrics (SCiP) device, a non-invasive spinal cord neuromodulation technology intended to treat children with cerebral palsy. The technology is designed to be used in conjunction with activity-based neurorehabilitation therapy with the goal of improving functional movement in such children. Through transcutaneous spinal nerve stimulation, the technique aims to model the passive connection between the brain and the spinal cord. In a recent pilot study, the company reports that 16 volunteer pediatric patients, with varying severity and age groups of cerebral palsy, demonstrated improved sensorimotor function after treatment with the device.

Cerebral palsy is a group of movement disorders that usually result from damage to the developing brain, with symptoms that affect posture, gait, and balance. Currently, there are no treatments to effectively treat cerebral palsy. Some patients undergo invasive surgery to try to address certain symptoms, such as spasticity, but there is a clear need for new effective treatments and less invasive alternatives.

This latest technology could provide a window into the cerebral palsy treatments of the future. The SCiP device is a non-invasive technique for transcutaneous spinal nerve stimulation. Designed to be used during physical rehabilitation, the technology aims to improve connections between the brain and spinal cord to enhance rehabilitation.

The company recently published the results of a pilot study in which the device was tested on a group of 16 children with cerebral palsy. The children received two interventions per week during the study. This included activity-based neurorehabilitation therapy where the children received neuromodulation therapy from the device. At the end of the 8-week study, the researchers reported that all treated children demonstrated improved sensorimotor function.

“At just three years old and very affected by cerebral palsy, our son has shown such exciting progress since starting SCiP,” said Dana, mother of one of the study participants. “We are so grateful that our son was included in the clinical trial with SCiP as it has opened up a world of possibilities for our son and we hope that others will be able to witness it soon.”

Watch a video about the exciting study below:

Study in Nature communication: A pilot study combining noninvasive spinal neuromodulation and activity-based neurorehabilitation therapy in children with cerebral palsy

Link: SpineX Company Website…

By: SpineX

Leave a Comment

Your email address will not be published. Required fields are marked *